A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas
Clinical trial NCT04308590 · COMPLETED
Trial details
- NCT number
- NCT04308590
- Sponsor
- Corcept Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2024-09-19
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.